Related Experiment Video
Updated: Aug 16, 2026

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)
Published on: December 26, 2015
[Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes]
Marian Szczepanik1, Monika Tutaj, Iwona Filipczak-Bryniarska
1Zakład Biologii Rozwoju Człowieka Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie. mmszczep@cyf-kr.edu.pl
Abstract:
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) leading to demyelinization. Although our knowledge on the pathomechanism of MS has evolved dramatically in recent years; however there is still no effective cure for MS. So far, non-specific immune suppressive agents are used to slow down the disease. Recently, there are many efforts to find a new method that would allow to control specifically unwanted immune response. It might be achieved by affecting antigen recognition or induction of "immune deviation".

